Effect of curcumin and three analogues on pre-osteoblast cells’ viability, differentiation, and gene expression
2024

Effects of Curcumin and Its Analogues on Bone Cells

publication Evidence: moderate

Author Information

Author(s): Sá Ana Flor, Diniz Ivana Márcia Alves, de Oliveira Renata Barbosa, Diniz Marina Gonçalves, Cortés Maria Esperanza, de Souza Letícia Lopes, Olórtegui Carlos Delfin Chávez, Lages Frederico Santos

Primary Institution: Universidade Federal de Minas Gerais – UFMG

Hypothesis

Can curcumin analogues improve the viability and differentiation of pre-osteoblast cells compared to natural curcumin?

Conclusion

The curcumin analogue RI75 shows enhanced biological activity and potential for promoting bone cell differentiation compared to natural curcumin.

Supporting Evidence

  • RI75 showed upregulation of SDF-1, a crucial factor in tissue regeneration.
  • DMAM and RI75 upregulated runx2 and vegf, both associated with osteodifferentiation.
  • RI75 demonstrated greater mineralization than curcumin.

Takeaway

This study found that a special version of curcumin, called RI75, helps bone cells grow better than regular curcumin.

Methodology

The study used pre-osteoblastic MC3T3-E1 cells treated with curcumin and its analogues to assess cell viability, differentiation, and gene expression.

Limitations

The study's findings may not fully translate to clinical settings due to the use of a cell line rather than primary cells.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/1807-3107bor-2024.vol38.0123

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication